HIV Testing & Womens Attitudes on HIV Vaccine Trials

PHASE3CompletedINTERVENTIONAL
Enrollment

2,031

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
HIV
Interventions
BEHAVIORAL

Message Sidedness

There are 16 pairs of messages varying in sidedness. Arm 1 is a no message control condition regarding HIV testing + a no message control condition regarding trial participation. Arm 2 is control + a 1-sided message. Arm 3 is control + a trivial 2-sided message. Arm 4 is control + a major 2-sided message. Arm 5 is a 1-sided message + a control. Arm 6 is a 1-sided message + a 1-sided message. Arm 7 is a 1-sided message + a trivial 2-sided message. Arm 8 is a 1-sided message + a major2-sided message. Arm 9 is a trivial 2-sided message + a control. Arm 10 is a trivial 2-sided message + a 1-sided message. Arm 11 is a trivial 2-sided message + a trivial 2-sided message. Arm 12 is a trivial 2-sided message + a major 2-sided message. Arm 13 is a major 2-sided message + a control. Arm 14 is a major 2-sided message + a 1-sided message. Arm 15 is a major 2-sided message + a trivial 2-sided message. Arm 16 is a major 2-sided message + a major2-sided message.

Trial Locations (1)

46202

Indiana University Medical Group Clinics, Indianapolis

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Nursing Research (NINR)

NIH

lead

Indiana University

OTHER

NCT00771537 - HIV Testing & Womens Attitudes on HIV Vaccine Trials | Biotech Hunter | Biotech Hunter